- Advertisement -
Pfizer has reported its earnings and sales more than doubled in the past quarter, and it has raised its outlook for results the full year, thanks greatly to its COVID-19 vaccine.
The company reported adjusted earnings of US$7.7 billion ($10.3 billion), up 133 per cent from a year earlier. Revenue…
